308 related articles for article (PubMed ID: 12911311)
1. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
Wilde C; Vogelsgesang M; Aktories K
Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
[TBL] [Abstract][Full Text] [Related]
2. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of the Rho-ADP-ribosylating exoenzyme C3stau2 from Staphylococcus aureus.
Wilde C; Just I; Aktories K
Biochemistry; 2002 Feb; 41(5):1539-44. PubMed ID: 11814347
[TBL] [Abstract][Full Text] [Related]
5. Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.
Holbourn KP; Sutton JM; Evans HR; Shone CC; Acharya KR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5357-62. PubMed ID: 15809419
[TBL] [Abstract][Full Text] [Related]
6. Rho-modifying C3-like ADP-ribosyltransferases.
Aktories K; Wilde C; Vogelsgesang M
Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.
Barth H; Hofmann F; Olenik C; Just I; Aktories K
Infect Immun; 1998 Apr; 66(4):1364-9. PubMed ID: 9529054
[TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions.
Narumiya S; Morii N; Sekine A; Kozaki S
J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805
[TBL] [Abstract][Full Text] [Related]
10. Rho-ADP-ribosylating exoenzyme from Bacillus cereus. Purification, characterization, and identification of the NAD-binding site.
Just I; Selzer J; Jung M; van Damme J; Vandekerckhove J; Aktories K
Biochemistry; 1995 Jan; 34(1):334-40. PubMed ID: 7819216
[TBL] [Abstract][Full Text] [Related]
11. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q.
Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I
FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765
[TBL] [Abstract][Full Text] [Related]
12. Characterization of C3larvinA, a novel RhoA-targeting ADP-ribosyltransferase toxin produced by the honey bee pathogen, Paenibacillus larvae.
Turner M; Tremblay O; Heney KA; Lugo MR; Ebeling J; Genersch E; Merrill AR
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31844879
[TBL] [Abstract][Full Text] [Related]
13. Active site mutation of the C3-like ADP-ribosyltransferase from Clostridium limosum--analysis of glutamic acid 174.
Böhmer J; Jung M; Sehr P; Fritz G; Popoff M; Just I; Aktories K
Biochemistry; 1996 Jan; 35(1):282-9. PubMed ID: 8555186
[TBL] [Abstract][Full Text] [Related]
14. Recognition of RhoA by Clostridium botulinum C3 exoenzyme.
Wilde C; Genth H; Aktories K; Just I
J Biol Chem; 2000 Jun; 275(22):16478-83. PubMed ID: 10748216
[TBL] [Abstract][Full Text] [Related]
15. Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Williamson KC; Smith LA; Moss J; Vaughan M
Trans Assoc Am Physicians; 1990; 103():281-8. PubMed ID: 2132538
[No Abstract] [Full Text] [Related]
16. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
[TBL] [Abstract][Full Text] [Related]
17. Conformational plasticity is crucial for C3-RhoA complex formation by ARTT-loop.
Tsuge H; Yoshida T; Tsurumura T
Pathog Dis; 2015 Dec; 73(9):ftv094. PubMed ID: 26474844
[TBL] [Abstract][Full Text] [Related]
18. Studies on the active-site structure of C3-like exoenzymes: involvement of glutamic acid in catalysis of ADP-ribosylation.
Aktories K; Jung M; Böhmer J; Fritz G; Vandekerckhove J; Just I
Biochimie; 1995; 77(5):326-32. PubMed ID: 8527485
[TBL] [Abstract][Full Text] [Related]
19. Channel formation by the binding component of Clostridium botulinum C2 toxin: glutamate 307 of C2II affects channel properties in vitro and pH-dependent C2I translocation in vivo.
Blöcker D; Bachmeyer C; Benz R; Aktories K; Barth H
Biochemistry; 2003 May; 42(18):5368-77. PubMed ID: 12731878
[TBL] [Abstract][Full Text] [Related]
20. From enzyme to zymogen: engineering Vip2, an ADP-ribosyltransferase from Bacillus cereus, for conditional toxicity.
Jucovic M; Walters FS; Warren GW; Palekar NV; Chen JS
Protein Eng Des Sel; 2008 Oct; 21(10):631-8. PubMed ID: 18723852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
